KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.95

Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials.

Abdenour Nabid, Nathalie Carrier, Eric Vigneault, André-Guy Martin, Jean-Paul Bahary, Thu Van Nguyen, Peter Vavassis, Sylvie Vass, Marc-André Brassard, Boris Bahoric, Robert Archambault, François Vincent, Redouane Bettahar, Marie Duclos, Derek Wilke, Luis Souhami

Radiother Oncol 195 110256

PMID38552845
PMCID-
DOI10.1016/j.radonc.2024.110256
发表日期2024-03-29
入排依据:Study meets oncology, human, randomized, Phase III, and original report criteria, but the primary outcome is testosterone recovery (a biological/pharmacokinetic endpoint), not a clinical efficacy time-to-event endpoint (OS, PFS, DFS, EFS, RFS, TTP) with a Kaplan-Meier or HR analysis.
摘要

摘要

BACKGROUND AND PURPOSE: To determine the rate and time of testosterone (T) recovery in patients (pts) with localised prostate cancer treated with radiotherapy plus 0-, 6-, 18- or 36-month of androgen deprivation therapy (ADT). MATERIALS AND METHODS: In 1230 pts with prostate cancer randomised into two phase III trials, serum T was measured at baseline, then regularly. T recovery rate was compared between normal vs. abnormal baseline T and with ADT duration with Chi-square test or Fisher's exact test. A multivariable logistic regression model to predict the probability of recovering normal T was performed. RESULTS: Overall, 87.4 % (167/191), 75.9 % (293/386), 54.8 % (181/330) and 43.2 % (80/185) of pts, recovered normal T on the 0-, 6-, 18- or 36-month schedule, respectively (p < 0.001). In patients recovering normal T, the median time to T recovery increased with ADT duration ranging from 0.31, 1.64, 3.06 to 5.0 years for the 0-, 6-, 18- or 36-month schedules, respectively (p < 0.001) and was significantly faster for those with a normal T at baseline (p < 0.001). On multivariable analysis, older age and longer ADT duration are associated with a lower T recovery. CONCLUSIONS: Testosterone recovery rate after ADT depends on several factors including hormonal duration, normal baseline T, age and medical comorbidities. A longer ADT duration is the most important variable affecting T recovery. The data from this report might be a valuable tool to help physicians and patients in evaluating risks and benefits of ADT.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。